butylhydroxybutylnitrosamine has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, DT; Lee, JT; Lee, SH; Lin, D; Luong, R; Peng, Y; Shaltouki, A; Sun, Z; Wang, Y | 1 |
| Carrascosa, MJ; Collado, M; Diaz-Meco, MT; Duran, A; Flores, JM; García-Cao, I; Martín-Caballero, J; Moscat, J; Serrano, M | 1 |
1 trial(s) available for butylhydroxybutylnitrosamine and Cancer of Prostate
| Article | Year |
|---|---|
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Cycle Proteins; DNA-Binding Proteins; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; HEK293 Cells; Heterozygote; Humans; Male; Mice; Mice, Knockout; Prostatic Neoplasms; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 2013 |
1 other study(ies) available for butylhydroxybutylnitrosamine and Cancer of Prostate
| Article | Year |
|---|---|
Tumour-suppression activity of the proapoptotic regulator Par4.
Topics: Age Factors; Animals; Apoptosis; Butylhydroxybutylnitrosamine; Endometrial Neoplasms; Estradiol; Female; Histological Techniques; Immunoblotting; Male; Mice; Mice, Mutant Strains; Phenotype; Prostatic Neoplasms; Proteins; Receptors, Thrombin; Testosterone; Urinary Bladder Neoplasms; X-Linked Inhibitor of Apoptosis Protein | 2005 |